Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Eclipse Surgical

This article was originally published in The Gray Sheet

Executive Summary

Eclipse Surgical: Amends pending premarket approval application for use of the TMR transmyocardial revascularization laser system to treat patients with severe angina caused by coronary artery disease. The original PMA was submitted July 1 ("The Gray Sheet" July 14, In Brief). The amendment includes 12-month follow-up data from a Phase II randomized, controlled study comparing TMR to drug therapy for Class IV angina patients who had no other surgical options...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009775

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel